SCHEMBL9954136

SCHEMBL9954136

CCOC(=O)C1CCc2nc(Nc3cccc(Cl)c3)ncc2C1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRM5 P41594 3/20 0.54
MAOB P27338 2/20 0.54
MAOA P21397 1/20 0.46
HSD17B10 Q99714 1/20 0.46
CDK5 Q00535 3/20 0.45
CDK5R1 Q15078 3/20 0.45
MAPT P10636 3/20 0.44
CCNA2 P20248 2/20 0.44
CDK2 P24941 2/20 0.44
CDK1 P06493 1/20 0.44
CCNB1 P14635 1/20 0.44
LMNA P02545 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.44
CNR2 P34972 6/20 0.43
SIRT5 Q9NXA8 1/20 0.43
KDM4E B2RXH2 1/20 0.43
ALDH1A1 P00352 1/20 0.43
CYP3A4 P08684 4/20 0.42
CYP2C9 P11712 4/20 0.42
CYP2C19 P33261 4/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9954113 0.85 GRM5 (0.61) GRM5MAOBMAOACDK5CDK5R1
SCHEMBL9959960 0.84 GRM5 (0.53) GRM5MAOBMAOACDK5CDK5R1
SCHEMBL9956217 0.84 GRM5 (0.57) GRM5MAOBMAOACDK5CDK5R1
SCHEMBL9954096 0.80 GRM5 (0.58) GRM5MAOBMAOACDK5CDK5R1
SCHEMBL9955865 0.79 PDGFRB (0.55) GRM5MAOBMAOAMAPTSIRT5
SCHEMBL9956051 0.76 GRM5 (0.59) GRM5MAOBMAOACDK5CDK5R1
SCHEMBL9955388 0.73 GRM5 (0.58) GRM5MAOBMAOAMAPTSIRT5
SCHEMBL23256873 0.73 GSK3B (0.61) HSD17B10MAPTLMNASMN1; SMN2KDM4E
SCHEMBL27366669 0.72 PDK1 (0.50) MAPTSMN1; SMN2KDM4EALDH1A1CYP2C19
SCHEMBL9954811 0.72 GRM5 (0.59) GRM5MAOBMAOAMAPTCNR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012085167-A1 METABOTROPIC GLUTAMATE RECEPTOR MODULATORS MERZ PHARMA GMBH & CO. KGAA (DE) 2012-06-28 WO disclosed